Letter to the Editor: From prediction to prevention: Integrating nomograms and pathogen biology in multidrug-resistant pyogenic liver abscess

The increasing incidence of multidrug-resistant (MDR) Gram-negative pyogenic liver abscess (PLA) is reshaping diagnostic and therapeutic paradigms in hepatobiliary medicine. The study by Xu et al, published in the recent issue of the World Journal of Gastroenterology, developed a predictive nomogram incorporating five independent factors-advanced age, diabetes, malignancy, lower C-reactive protein levels, and prolonged prothrombin time-to estimate individualized MDR risk. This letter critically examines the methodological and clinical implications of that model, discussing how predictive analytics may evolve into preventive frameworks when combined with biological insight and stewardship integration. The proposed nomogram is a practical bedside instrument that operationalizes MDR risk estimation in clinical environments increasingly dominated by Klebsiella pneumoniae and Escherichia coli. Its discrimination is robust, though single-center derivation constrains external validity. Augmenting predictive accuracy through dynamic biomarkers-such as interleukin-6 and procalcitonin-could better capture host-response kinetics. Mechanistic evidence indicates that MDR strains' enhanced virulence (biofilm formation, siderophore-mediated iron uptake, capsule hyperexpression) supports integrating pathogen biology into prediction. Embedding risk models within antimicrobial stewardship pathways may promote timely source control, rational empiric therapy, and structured de-escalation. Beyond statistical modeling, innovation lies in transforming prediction into prevention. Multicenter validation, genomic correlation, and digital recalibration will determine whether predictive tools can reduce MDR-PLA burden. Aligning data-driven analytics with infection biology and governance can shift hepatology from reactive treatment toward proactive resistance prevention.